Tower Research Capital LLC (Trc) Rani Therapeutics Holdings, Inc. Call Options Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.42 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$944,0710.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$656,4661.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$596,4940.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$402,6480.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $32.6M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...